Exane Asset Management Portfolio Holdings

Exane Asset Management

  • $107 Million
  • Q3 2024

Exane Asset Management has filed its 13F form on November 05, 2024 for Q3 2024 where it was disclosed a total value porftolio of $107 Million distributed in 18 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ubs Group Ag with a value of $31.5M, Bank Of America Corp with a value of $17M, Coca Cola Europacific Partners PLC with a value of $14.9M, Stellantis N.V. with a value of $14.2M, and T Mobile Us, Inc. with a value of $9.82M.

Examining the 13F form we can see an increase of $2.79M in the current position value, from $104M to 107M.

Below you can find more details about Exane Asset Management portfolio as well as his latest detailed transactions.

Portfolio value $107 Million
Financial Services: $48.6 Million
Consumer Cyclical: $19.7 Million
Consumer Defensive: $14.9 Million
Communication Services: $9.82 Million
Technology: $5.14 Million
Basic Materials: $5.07 Million
Healthcare: $4.06 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$101B
$31.5 Million 29.41% of portfolio
1,019,905
Q3 2024 Added 353.75%
$377B
$17 Million 15.85% of portfolio
428,025
Q3 2024 New
$35.7B
$14.9 Million 13.88% of portfolio
188,861
Q3 2024 Added 24.47%
$41.9B
$14.2 Million 13.21% of portfolio
1,008,069
Q3 2024 Reduced 25.37%
$296B
$9.82 Million 9.16% of portfolio
47,585
Q3 2024 Added 10.12%
$2.01T
$5.5 Million 5.14% of portfolio
29,541
Q3 2024 Added 11.3%
$23.2B
$5.07 Million 4.73% of portfolio
48,374
Q3 2024 Reduced 25.2%
$42.1B
$3.09 Million 2.88% of portfolio
30,851
Q3 2024 Added 49.1%
$518B
$1.55 Million 1.45% of portfolio
9,096
Q3 2024 Added 18.13%
$10.5B
$1.09 Million 1.02% of portfolio
17,700
Q3 2024 New
$10.3B
$1.08 Million 1.0% of portfolio
14,000
Q3 2024 New
$80B
$981,000 0.92% of portfolio
3,500
Q3 2024 New
$22.7B
$969,000 0.9% of portfolio
5,000
Q3 2024 New
$3.11T
$442,000 0.41% of portfolio
1,029
Q3 2024 Reduced 30.0%
$135B
$38,000 0.04% of portfolio
610
Q3 2024 Reduced 99.62%
$23.9B
$0 0.0% of portfolio
-
Q3 2024 Reduced 54.09%
Apogee Therapeutics Inc Com
-
$0 0.0% of portfolio
-
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 18
  • Current Value $107 Million
  • Prior Value $104 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 05, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 7 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Exane Asset Management Portfolio

Follow Exane Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Exane Asset Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email